These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3044983)

  • 1. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
    J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
    Togna AR; Del Giudice G; Verdini AS; Bonelli F; Pessi A; Engers HD; Corradin G
    J Immunol; 1986 Nov; 137(9):2956-60. PubMed ID: 2428881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against malaria: initial trial with an ant-sporozoite vaccine, (NANP)3-TT (RO 40-2361) in Africa (Bobo-Dioulasso, Burkina Faso)].
    Guiguemdé TR; Sturchler D; Ouédraogo JB; Drabo M; Etlinger H; Douchet C; Gbary AR; Haller L; Kambou S; Fernex M
    Bull Soc Pathol Exot; 1990; 83(2):217-27. PubMed ID: 2119897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.
    Stürchler D; Zimmer G; Berger R; Etlinger H; Fernex M; Matile H; Just M
    Bull World Health Organ; 1990; 68 Suppl(Suppl):38-41. PubMed ID: 2094589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
    Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
    Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF; Branigan J; Smith G; Houghten RA
    Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
    J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
    Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
    Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
    Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
    Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
    Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
    Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
    Epstein JE; Charoenvit Y; Kester KE; Wang R; Newcomer R; Fitzpatrick S; Richie TL; Tornieporth N; Heppner DG; Ockenhouse C; Majam V; Holland C; Abot E; Ganeshan H; Berzins M; Jones T; Freydberg CN; Ng J; Norman J; Carucci DJ; Cohen J; Hoffman SL
    Vaccine; 2004 Apr; 22(13-14):1592-603. PubMed ID: 15068840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary responses to (NANP) peptides by Plasmodium falciparum sporozoites in various strains of mice.
    Del Giudice G; Cheng Q; Mazier D; Meuwissen JH; Grau GE; Corradin G; Pessi A; Verdini AS; Lambert PH
    Scand J Immunol; 1989 May; 29(5):555-62. PubMed ID: 2471257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
    Etlinger HM; Trzeciak A
    Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM; de Oliveira GA; Clavijo P; Maracic M; Tam JP; Lu YA; Nardin EH; Nussenzweig RS; Cochrane AH
    J Immunol; 1993 Feb; 150(4):1403-12. PubMed ID: 7679427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.